Coloplast AS (OTCPK:CLPBF)
$ 128.575 7.425 (6.13%) Market Cap: 28.76 Bil Enterprise Value: 31.84 Bil PE Ratio: 39.13 PB Ratio: 11.87 GF Score: 94/100

Q2 2022 Coloplast A/S Earnings Call Transcript

May 05, 2022 / 01:00PM GMT
Release Date Price: $139.23 (-0.91%)
Operator

Hello, and welcome to the Coloplast Interim Financial Statements for Q2 2022. (Operator Instructions) And today, I'm pleased to present Kristian Villumsen, President and CEO. Please begin your meeting.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you, operator. Good afternoon, and welcome to our half year '21/'22 conference call. My name is Kristian Villumsen, CEO of Coloplast. I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We will start with a short presentation by Anders and myself and then open up for all of the questions that you may have.

Please turn to Slide #3. In Q2, we delivered 7% organic growth and an EBIT margin before special items of 31%. We delivered a respectable return on invested capital of 25% after tax and before special items, which is naturally impacted by the recent acquisition of Atos Medical. Reported growth in Danish kroner was 16% and Atos Medical contributed 6 percentage points to the reported growth and delivered high single

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot